Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer
- 25 April 2009
- journal article
- review article
- Published by Elsevier
- Vol. 18 (3) , 268-274
- https://doi.org/10.1016/j.suronc.2009.02.004
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation InteractionsInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- Combined Prostate Brachytherapy and Short-Term Androgen Deprivation Therapy as Salvage Therapy for Locally Recurrent Prostate Cancer After External Beam IrradiationJournal of Urology, 2006
- Identifying Patients at Risk for Significant Versus Clinically Insignificant Postoperative Prostate-Specific Antigen FailureJournal of Clinical Oncology, 2005
- SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: CONTEMPORARY OUTCOMESJournal of Urology, 2005
- Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen eraCancer, 2004
- Biochemical Disease-Free Survival in Men Younger Than 60 Years With Prostate Cancer Treated With External Beam RadiationJournal of Urology, 2002
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- PREDICTIVE VALUE OF PROSTATE SPECIFIC ANTIGEN NADIR AFTER SALVAGE CRYOTHERAPYJournal of Urology, 1998